Omeros Corporation   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Seattle WA United States (1994)

Organization Overview

First Clinical Trial
2004
NCT00245271
First Marketed Drug
2014
phenylephrine (Prefrin)
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

OMEROS | Omeros Corporation